Introduction {#s1}
============

Autism and other developmental disabilities, clinically referred to as autism spectrum disorders (ASDs), are characterized by impairments in communication skills and social interaction, and the presence of repetitive stereotyped behaviors and interests. It is typically diagnosed by the age of three and has a prevalence rate of 60-70 per 10,000 children in broader diagnostic criteria as per the most recent estimates [@pone.0023738-Fombonne1]. ASDs are considered to be among the most heritable of all psychiatric disorders. A recent largest population based twin study comprised of 10,895 twin pairs, reported 80% heritability for ASDs [@pone.0023738-Lichtenstein1], confirming the previously reported heritability estimates [@pone.0023738-Bailey1], [@pone.0023738-Steffenburg1]. Linkage, candidate gene and whole genome association studies have suggested several genes and chromosomal regions associated with the disorder. However, none of these known causes individually account for more than 1--2% of the cases, and specific genetic mechanisms underlying the heritability of the disorder still remain largely cryptic. It was found that many different genetic changes in unrelated genes can cause indistinguishable ASD features; this genetic heterogeneity necessitate the need to look for more potential candidate genes associated with the disorder.

The LIM homeodomain transcription factor 1b (LMX1B) was initially characterized as a key regulator of the normal dorsoventral patterning in the developing limbs [@pone.0023738-Johnson1]. Several mutations reported in this gene have been found to lead to the pleiotropic phenotype, the nail platella syndrome [@pone.0023738-Knoers1]--[@pone.0023738-Marini1]. Later, the role of *Lmx1b* in the development and maintenance of serotoninergic (5HTergic) neurons in the central nervous system (CNS) was reported, and thereafter, underlying mechanisms were studied in detail. *Lmx1b* knock-out mice were found to be lacking the entire central 5HTergic neurons [@pone.0023738-Ding1], [@pone.0023738-Zhao1]. Further, it was shown that overexpression of *Lmx1b* enhances differentiation of mouse embryonic stem cells into 5HT neurons [@pone.0023738-Dolmazon1]. In addition to its role in the development of central 5HTeregic neurons, *Lmx1b* is also required for the normal biosynthesis of 5HT in adult brain, and possibly for the regulation of normal functions of 5HTergic neurons [@pone.0023738-Song1].

A role of 5HTergic system in the pathophysiology of autism was proposed based on following observations, a) hyperserotonemia in the whole blood cells and platelets of 25--50% of patients with autism [@pone.0023738-Cook1], [@pone.0023738-Anderson1], b) depletion of tryptophan, the 5HT precursor, in ASD patients increased some stereotype behaviors associated with the disorder [@pone.0023738-McDougle1], c) treatment with selective serotonin reuptake inhibitors has shown to be effective in ameliorating the repetitive and/or compulsive behaviors in some autistic individuals [@pone.0023738-Kolevzon1] and d) recent neuroimaging studies have shown low levels of brain 5HT synthesis in autistic children [@pone.0023738-Chandana1] and reduction in serotonin transporter (SLC6A4) binding in different brain regions of both children and adults with the disorder [@pone.0023738-Makkonen1], [@pone.0023738-Nakamura1]. Compliant with these reports, several genetic association studies involving genes in the 5HT metabolism with a focus on the *SLC6A4* were also attempted. While several *SLC6A4* polymorphisms were shown to be associated with the disorder in some studies [@pone.0023738-McCauley1], [@pone.0023738-Sutcliffe1], others failed to replicate the findings [@pone.0023738-Ramoz1].

Taking together, these results provide compelling, though inconsistent evidence for the role of 5HTergic system in the pathophysiologic mechanism of ASDs. In view of the importance of LMX1B in the development of 5-HTergic neurons, it would be interesting to study its role in autism. Here we performed a trio-based study to examine the association of *LMX1B* with autism. We also assessed any alterations in the expression *LMX1B* in the postmortem brain samples of autism patients as compared to healthy controls.

Results {#s2}
=======

Single SNP TDT {#s2a}
--------------

Mendelian inheritance inconsistencies were not observed for any of the SNPs. For each SNP, \>99% of the genotypes were scored; none of the SNPs showed deviation from HWE.

The results of TDT analysis are shown in [Table 1](#pone-0023738-t001){ref-type="table"}. rs10732392 (p = 0.018; OR = 1.764; 95% CI for OR 1.095--2.842) and rs12336217 (p = 0.022; OR = 1.748; 95% CI for OR 1.076--2.841) showed significant associations with autism. However, these associations did not withstand the multiple testing correction. Overtransmission was observed for the minor allele A (62.82%) of rs10732392 and for minor allele G (62.67%) of rs12336217.

10.1371/journal.pone.0023738.t001

###### Single SNP TDT results of *LMX1B* SNPs in 252 trio samples.

![](pone.0023738.t001){#pone-0023738-t001-1}

  Marker    db SNP ID     Genomic    Variation[\*](#nt102){ref-type="table-fn"}   Location   Minor allele   T (%)[‡](#nt104){ref-type="table-fn"}   *p*-value^§^
  -------- ------------ ----------- -------------------------------------------- ---------- -------------- --------------------------------------- --------------
  SNP 1     rs10732392   129396037                      G:A                       Intron 2      0.078                       48.92                   ***0.018***
  SNP 2     rs10760444   129396434                      A:G                       Intron 2      0.449                       48.23                      0.214
  SNP 3     rs10448285   129397014                      C:T                       Intron 2      0.376                       50.64                      0.601
  SNP 4     rs12336217   129399870                      A:G                       Intron 2      0.075                       48.98                   ***0.022***
  SNP 5     rs7858338    129406644                      T:C                       Intron 2       0.26                       51.61                      0.085
  SNP 6     rs11793373   129407543                      G:A                       Intron 2      0.252                       50.6                       0.513
  SNP 7     rs10819190   129408513                      G:A                       Intron 2      0.414                       49.56                      0.739
  SNP 8     rs6478750    129409198                      T:C                       Intron 2      0.408                       49.91                      0.948
  SNP 9     rs12555734   129411242                      C:A                       Intron 2       0.24                       51.25                       0.16
  SNP 10    rs13285227   129413298                      C:T                       Intron 2      0.348                       49.11                      0.439
  SNP 11     rs944103    129413490                      G:A                       Intron 2      0.472                       49.05                      0.526
  SNP 12    rs12555176   129414303                      G:T                       Intron 2      0.074                       50.11                      0.809
  SNP 13    rs7854658    129414938                      G:A                       Intron 2       0.21                       50.57                      0.486
  SNP 14    rs10987386   129416317                      C:T                       Intron 2      0.191                       49.5                       0.519
  SNP 15    rs12551234   129417809                      G:C                       Intron 2      0.407                       49.92                      0.949
  SNP 16    rs7853174    129419990                      G:A                       Intron 2      0.394                       49.04                      0.452
  SNP 17    rs10819194   129422023                      G:A                       Intron 2      0.422                       51.78                      0.189
  SNP 18    rs4322101    129428677                      A:G                       Intron 2      0.416                       51.19                       0.37
  SNP 19    rs7030919    129438872                      A:G                       Intron 2      0.115                       49.49                       0.37
  SNP 20    rs3737048    129458092                      G:T                       Intron 6      0.107                       50.39                      0.474
  SNP 21    rs10987413   129459438                      G:A                          3′         0.333                       50.65                       0.56
  SNP 22    rs10760450   129459628                      C:T                          3′          0.21                       50.58                      0.475
  SNP 23    rs10733682   129460914                      G:A                          3′         0.486                       51.27                       0.41
  SNP 24    rs4083644    129461714                      C:T                          3′          0.28                       49.93                      0.943

T: Transmitted.

\*Common allele is listed first.

†Based on the parental genotypes of 252 trios.

‡T% of common allele is listed, § Computed on the basis of likelihood ratio test; significant p-values (\<0.05) are indicated in bold italics.

LD analysis {#s2b}
-----------

LD analysis based on D\' values identified six distinct haploblocks across *LMX1B* gene. The first block consists of SNPs 01 to 06, the second block SNPs 08 and 09, the third block 10 and 11, fourth block 12 to 16, fifth block 18 and 19 and the sixth block included SNPs 20 to 22 ([Figure 1](#pone-0023738-g001){ref-type="fig"}).

![Haploblock structure of *LMX1B.*\
Six haplotype blocks were identified based on D\' values calculated from 252 trios.](pone.0023738.g001){#pone-0023738-g001}

Haplotype TDT {#s2c}
-------------

The results of haplotype TDT is given in [Table 2](#pone-0023738-t002){ref-type="table"}. Based on the LD structure of *LMX1B,* associations of haplotypes in the six haploblocks were analysed. The haplotype AGCGTG of the first block showed significant association with autism (p = 0.008).

10.1371/journal.pone.0023738.t002

###### Haplotype associations of SNPs belonging to the six LD blocks of *LMX1B*, in 252 trios.
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  Block                    Haplotype[\*](#nt107){ref-type="table-fn"}   Frequency   T(%)    Individual *p-*   Permutation *p*-   Block *p*-
  ----------------------- -------------------------------------------- ----------- ------- ----------------- ------------------ ------------
  Block 1 (SNPs 01--06)                      GGTATG                       0.355     51.67       0.6291               1          
                                             GACATA                       0.25      48.81       0.7487               1          
                                             GACACG                       0.244     45.71       0.2568             0.994        
                                             AGCGTG                       0.073     66.13    ***0.0079***          0.114        
                                             GACATG                       0.052     51.42       0.8461               1          
                                             GGTACG                       0.014     30.77       0.1658              0.97           0.096
  Block 2 (SNPs 08--09)                        CC                         0.406     50.23       0.9432               1          
                                               TC                         0.353     54.03       0.2242             0.987        
                                               TA                         0.239     44.23       0.1255             0.892           0.258
  Block 3 (SNPs 10--11)                        CG                         0.525     48.4        0.6123               1          
                                               TA                         0.345     52.71       0.4094               1          
                                               CA                         0.126     48.79       0.8046               1             0.731
  Block 4 (SNPs 12--16)                      GGCGA                        0.379     53.41       0.3114             0.998        
                                             GGCGG                        0.209     45.31       0.2362             0.991        
                                             GACCG                        0.201     48.99       0.8072               1          
                                             GGTCG                        0.119     55.41       0.2624             0.994        
                                             TGTCG                        0.071     48.81       0.8455               1             0.595
  Block 5 (SNPs 18--19)                        AA                         0.58      52.42       0.4476               1          
                                               GA                         0.304     47.25       0.1587             0.966        
                                               GG                         0.112     53.61       0.4772               1             0.354
  Block 6 (SNPs 20--22)                       GGC                         0.35      55.39        0.111             0.868        
                                              GAC                         0.332     48.19        0.59                1          
                                              GGT                         0.21      47.63       0.5365               1          
                                              TGC                         0.107     46.45       0.4947               1             0.512

T: Transmitted / (Transmitted + Untransmitted).

‡10,000 permutations.

\*All possible combinations of haplotypes with frequency \>0.01 †Significant *p*-values (\<0.05) are indicated in bold italics.

*LMX1B* expression in the postmortem brains {#s2d}
-------------------------------------------

No significant difference in age, sex and postmortem intervals was observed between autism and control groups in all the brain regions (ACG, MC and THL). There was a significant difference in *LMX1B* expression between the autism and control group in the ACG (p = 0.049) ([Figure 2](#pone-0023738-g002){ref-type="fig"}). Expression was significantly lower in autism groups with a fold change of (2^−△△C^T) 0.43. No *LMX1B* expression could be detected in the other two brain regions (MC and TH).

![*LMX1B* expression in the brain.\
*LMX1B* expression in the anterior cingulate gyrus region of the brain of autism patients compared to that of control samples.](pone.0023738.g002){#pone-0023738-g002}

Discussion {#s3}
==========

In this study, we examined the association of the transcription factor gene *LMX1B* with autism in Caucasian population. In the trio-based study, we found nominal associations for two SNPs (rs10732392 and rs12336217) and a haplotype with autism. To the best of our knowledge, this is the first study which reported an association between *LMX1B* and autism; a previous study reported the association between *LMX1B* and schizophrenia [@pone.0023738-Bergman1], which is also a neurodevelopmental disorder. Both the SNPs which are found to be associated with the disorder are located in the introns (intron 2) and may lack any direct functional importance. We also found that the *LMX1B* mRNA expression in general, is rather low in adult brain; detected only in ACG. However, *LMX1B* mRNAs were found to be significantly lower in the ACG of autistic brains than the similar regions of control brain tissues.

Multiple lines of evidence suggested a serotoninergic dysfunction in many patients with autism, although the results are still inconclusive. Involvement of several transcription factors are reported in the 5HTergic differentiation. In mammalian CNS, a sequential activation of transcription factors in the hindbrain, starting with the regulation of the expression of *Nkx2-2* by the *Shh* signaling pathway, has been proposed [@pone.0023738-Ding1]. It was observed that 5HT neurons are absent in the mice lacking *Nkx2-2* [@pone.0023738-Pattyn1]. It occupies the highest hierarchical position in the genetic cascade that involved in the development of 5HT neurons. Another transcription factor *Pet1*, expressed in the post mitotic 5HT neurons was reported to be the terminal differentiation factor, which acts in the final step of the transcriptional cascade that establishes the final identity of 5HT neurons. Mice lacking *Pet1* had 70--80% fewer 5-HT neurons than normal mice. The *Lmx1b* ablation does not affect the expression Nkx2.2 and Shh [@pone.0023738-Ding1], [@pone.0023738-Cheng1] putting these factors upstream of Lmx1b. However, during development, *Lmx1b* precedes *pet1*, and *Lmx1b* knock-out mice showed loss of *Pet1* expression [@pone.0023738-Zhao1]. *In vivo*, *Pet1* expression was increased in neurons overexpressing *Lmx1b* [@pone.0023738-Dolmazon1]. Thus, *Lmx1b* has been proposed as an essential link between Nkx2.2 and Pet1 in the genetic cascade that controls the early specification and terminal differentiation of 5HTergic neurons in the hindbrain. Lmx1b expression was shown to be the rate limiting step in this cascade of events for specifying the 5HT phenotype [@pone.0023738-Dolmazon1]. Further, Lmx1b, together with Pet1, is also involved in the serotonin metabolism as it controls a set of molecules essential for the serotonin synthesis (TPH2), vesicular transport (VMAT2) and reuptake after synaptic release (SLC6A4) in the developing as well as adult brain [@pone.0023738-Zhao1], [@pone.0023738-Song1].

ACG region plays important role in the pathophysiology of autism as shown by previous reports [@pone.0023738-Haznedar1], [@pone.0023738-Ohnishi1]. Our positron emission tomography studies had shown that a reduction in SLC6A4 binding in the cingulate cortices is associated with an impairment of social cognition in autistic subjects [@pone.0023738-Nakamura1]. The present finding of reduced *LMX1B* expression in the ACG of autism group, therefore, could have some deleterious effects on the serotonergic system, given the role of LMX1B in the differentiation of 5HT neurons in developing brain, and in the maintenance of 5HT system in adult brain.

In conclusion, we report a possible association of the transcription factor *LMX1B* with autism pathogenesis. However, our results should be interpreted with some caution, given the limitations in sample size of postmortem brain samples and the modest associations we found in genetic and gene expression studies.

Materials and Methods {#s4}
=====================

Subjects {#s4a}
--------

DNA samples from trio families recruited to the Autism Genetic Resource Exchange [@pone.0023738-Geschwind1] were used for the single nucleotide polymorphism (SNP) association study. We selected 252 trios families with male offspring scored for autism. Only Caucasians (white) were selected and non-idiopathic autism cases were excluded.

Brain samples {#s4b}
-------------

Frozen postmortem brain tissues from autistic patients and controls were provided by the Autism Tissue Program (ATP; Princeton, NJ; <http://www.autismtissueprogram.org>) and Harvard Brain Tissue Research Center (HBTRC; Belmont, MA; <http://www.brainbank.mclean.org/>). Tissues were obtained from three brain regions important in cognitive and behavior processing namely a) anterior cingulate gyrus (ACG- 8 autism and 13 controls), b) motor cortex (MC- 7 autism and 8 controls), and c) thalamus (THL-8 autism and 9 controls). The demographic features of the samples are described in [Table 3](#pone-0023738-t003){ref-type="table"}.

10.1371/journal.pone.0023738.t003

###### Postmortem brain tissue information.

![](pone.0023738.t003){#pone-0023738-t003-3}

  Sample ID[a](#nt108){ref-type="table-fn"}    Diagnosis   Age (years)   Gender   PMI (hours)         Race               Cause of death          Brain regions[b](#nt109){ref-type="table-fn"}
  ------------------------------------------- ----------- ------------- -------- ------------- ------------------ ----------------------------- -----------------------------------------------
  UMB 818                                       Control        27          M          10           Caucasian            Multiple injuries                             ACG
  UMB 1065                                      Control        15          M          12           Caucasian            Multiple injuries                          ACG, THL
  UMB 1297                                      Control        15          M          16        African American        Multiple injuries                        ACG, MC, THL
  UMB 1407                                      Control         9          F          20        African American             Asthma                              ACG, MC, THL
  UMB 1541                                      Control        20          F          19           Caucasian              Head injuries                          ACG, MC, THL
  UMB 1649                                      Control        20          M          22            Hispanic            Multiple injuries                        ACG, MC, THL
  UMB 1708                                      Control         8          F          20        African American   Asphyxia, multiple injuries                   ACG, MC, THL
  UMB 1790                                      Control        13          M          18           Caucasian            Multiple injuries                             ACG
  UMB 1793                                      Control        11          M          19        African American            Drowning                             ACG, MC, THL
  UMB 1860                                      Control         8          M           5           Caucasian           Cardiac Arrhythmia                             ACG
  UMB 4543                                      Control        28          M          13           Caucasian            Multiple injuries                        ACG, MC, THL
  UMB 4638                                      Control        15          F           5           Caucasian             Chest injuries                               ACG
  UMB 4722                                      Control        14          M          16           Caucasian            Multiple injuries                        ACG, MC, THL
  UMB 797                                       Autism          9          M          13           Caucasian                Drowning                               ACG, THL
  UMB 1638                                      Autism         20          F          50           Caucasian                 Seizure                             ACG, MC, THL
  UMB 4231                                      Autism          8          M          12        African American            Drowning                             ACG, MC, THL
  UMB 4721                                      Autism          8          M          16        African American            Drowning                             ACG, MC, THL
  UMB 4899                                      Autism         14          M           9           Caucasian                Drowning                             ACG, MC, THL
  B 5000                                        Autism         27          M          8.3              NA                      NA                                ACG, MC, THL
  B 6294                                        Autism         16          M          NA               NA                      NA                                ACG, MC, THL
  B 6640                                        Autism         29          F         17.83             NA                      NA                                ACG, MC, THL

Autism Tissue Program (ATP) identifier.

Brain regions for which, each sample was available.

M: Male; F: Female, PMI: Postmortem interval, ACG: Anterior cingulate gyrus; MC: Motor cortex; THL: Thalamus; NA: Not available.

Selection of SNPs {#s4c}
-----------------

*LMX1B*, located in 9q33.3 (129,376,748 -- 129,463,311), is 86.56kb in size and consists of eight exons. The genomic structure is based on the UCSC (<http://www.genome.ucsc.edu>) assembly of the human genome. SNPs for the association studies were selected using the information from international HapMap project (<http://www.hapmap.org>) and National Centre for Biotechnology Information (NCBI dbSNP: <http://www.ncbi.nlm.nih.gov/SNP>). On the basis of their genomic locations and minor allele frequencies (MAF \>0.1), 24 SNPs were selected ([Figure 3](#pone-0023738-g003){ref-type="fig"}; [Table 1](#pone-0023738-t001){ref-type="table"}), using the pair-wise tagging option of Haploview.v4.1 (<http://www.broad.mit.edu/mpg/haploview>).

![Genomic structure of *LMX1B* gene.\
Locations of SNPs selected for the association study, based on the HapMap data on Caucasian population, are denoted by arrows. Exons are indicated by boxes.](pone.0023738.g003){#pone-0023738-g003}

Genotyping {#s4d}
----------

Assay-on-demand/Assay-by-design SNP genotyping products (ABI, Foster City, CA, USA) were used to score SNPs, based on the TaqMan assay method [@pone.0023738-Ranade1]. Genotypes were determined in ABI PRISM 7900HT Sequence Detection System (SDS) (Applied Biosystems), and analyzed using SDS v2.0 (ABI).

Statistical Analysis {#s4e}
--------------------

PedCheck v1.1 (<http://www.watson.hgen.pitt.edu>) was used to identify and eliminate all Mendelian inheritance inconsistencies in the trio genotype data. SNPs were tested for Hardy--Weinberg Equilibrium (HWE) using Haploview. SNP associations were examined by transmission disequilibrium test (TDT), using the TDTPHASE option of UNPHASED v2.403 (<http://portal.litbio.org>); expectation maximization (EM) algorithm was used to resolve uncertain haplotypes, to infer missing genotypes and to provide maximum-likelihood estimation of frequencies.

A linkage disequilibrium (LD) plot was constructed using the D\' values. Pair-wise LD values between SNPs were estimated using Haploview. Subsequently, associations of haplotypes (frequency \>0.01) belonging to the various haploblocks of *LMX1B* were also examined using Haploview.

Extraction of RNA from brain tissues {#s4f}
------------------------------------

The brain tissues were homogenized by ultrasonication and total RNA was extracted using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA), in accordance with the manufacturer\'s protocol. The RNA samples were further purified using RNeasy Micro Kit (QIAGEN GmbH, Hilden, Germany), following the manufacturer\'s instructions. The quantity (absorbance at 260 nm) and quality (ratio of absorbance at 260 nm and 280 nm) of RNA were estimated with a NanoDrop ND-1000 Spectrophotometer (Scrum, Tokyo, Japan).

Quantitative real-time reverse transcriptase PCR (qRT-PCR) {#s4g}
----------------------------------------------------------

ImProm-II Reverse Transcription System (Promega, Madison, WI, USA) was used to synthesize first-strand cDNA from the total RNA according to the manufacturer\'s protocol.

RT-PCR primers for *LMX1B* (NM_001174146.1) (F-cctttgagcaagtaaggataatgaatg, R-gggactgaatttcccagcaa) and endogenous reference *GAPDH* (NM_002046.3) (F-atcagcaatgcctcctgcac, R-tggcatggactgtggtcatg) were designed using primer express v2.0 (Applied Biosystems). SYBR Green qRT-PCR assays were performed using QuantiTect SYBR Green PCR kit (Qiagen). All the reactions were performed in triplicate, in the ABI PRISM 7900HT Sequence Detection System. C~T~ values, which reflect the mRNA expression levels, were determined. *LMX1B* C~T~ of each sample was normalized to the corresponding C~T~ for the internal control by calculating △C~T~ (△C~T~  = Target gene C~T~ -- *GAPDH* C~T~) to obtain the relative mRNA expression of the target gene. Quantification of the gene expression was performed by calculating △△C~T~ (△△C~T~  =  △C~T~ of the autistic group - △C~T~ of the control group).The fold change in gene expression between the two groups was determined by calculating 2^−△△C^T.

Statistical analysis {#s4h}
--------------------

For the gene expression studies, statistical calculations were performed using PSAW statistics 18.0 software (IBM-SPSS, Tokyo, Japan). The difference in age and postmortem interval between autistic and control groups was examined by t-test. The chi-square test was used to examine the sex distribution; alteration in gene expression between the two groups was analyzed by Mann-Whitney U-test.
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